{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T17:48:36Z","timestamp":1794505716882,"version":"4.9.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Postdoctoral Fellowship Program of CPSF","award":["GZC20230170"],"award-info":[{"award-number":["GZC20230170"]}]},{"name":"National Key Research and Development Program of China","award":["2022YFF1203001"],"award-info":[{"award-number":["2022YFF1203001"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["72125009"],"award-info":[{"award-number":["72125009"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Chinese Scientific and Technical Innovation Project 2030","award":["2018AAA0102100"],"award-info":[{"award-number":["2018AAA0102100"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2019-I2M-5-046"],"award-info":[{"award-number":["2019-I2M-5-046"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>It remains unclear whether anti-hypertensive medication use is associated with cognitive aging in general Chinese middle-aged and older adults, as well as the interplay with socioeconomic status (SES). We aim to examine associations of anti-hypertensive medication adherence, SES, and cognitive aging in Chinese middle-aged and older adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Our study was based on the China Health and Retirement Longitudinal Study, an ongoing longitudinal national survey recruiting community-dwelling adults aged\u2009\u2265\u200945 years. Baseline anti-hypertensive medication use was assessed at wave 1. Longitudinal adherence to anti-hypertensive medication was assessed during waves 1 and 2. SES was assessed using income, education, employment, and medical insurance. The annual rate of cognitive change was assessed using cognitive Z scores. Linear mixed models were used to examine longitudinal associations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 9229 participants were included (mean [SD] age: 57.1 [8.9] years; men: 50.8%). After controlling for blood pressure and other characteristics, participants taking anti-hypertensive medication at baseline, compared to participants not using medication, had a significantly decelerated decline in global cognition (\u03b2\u2009=\u20090.014; 95% confidence interval [CI], 0.003 to 0.025 SD\/year;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.01) and memory (\u03b2\u2009=\u20090.021; 95% CI, 0.008 to 0.034 SD\/year;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.001), respectively. Similarly, participants with high anti-hypertensive medication adherence during follow-up had slower declines in global cognition (\u03b2\u2009=\u20090.014; 95% CI, 0.002 to 0.027 SD\/year;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.02) and memory (\u03b2\u2009=\u20090.023; 95% CI, 0.008 to 0.038 SD\/year;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.003), compared to the low adherence group. There were no significant differences in cognitive decline between hypertension participants using or persistently adhering to medication and normotension participants. The SES significantly interacted with anti-hypertensive medication in associations with cognitive aging, with more evident associations observed in low SES subgroup (all\n                      <jats:italic>P<\/jats:italic>\n                      for interaction\u2009&lt;\u20090.05). Several sensitivity analyses were conducted, observing consistent findings.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Adhering to anti-hypertensive medication was associated with decelerated cognitive aging in Chinese community-dwelling middle-aged and older adults, especially in participants with low SES. These findings indicate that promoting anti-hypertensive medication use could be important to achieve healthy and inclusive cognitive aging in general Chinese middle-aged and older adults living with hypertension.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-025-03949-8","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T11:11:25Z","timestamp":1740481885000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Anti-hypertensive medication adherence, socioeconomic status, and cognitive aging in the Chinese community-dwelling middle-aged and older adults\u2009\u2265\u200945 years: a population-based longitudinal study"],"prefix":"10.1186","volume":"23","author":[{"given":"Chenglong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daijun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"3949_CR1","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396:413\u201346.","journal-title":"Lancet"},{"key":"3949_CR2","unstructured":"Alzheimer\u2019s Disease International. World Alzheimer Report 2023 Reducing dementia risk: never too early, never too late. 2023. https:\/\/www.alzint.org\/resource\/world-alzheimer-report-2023\/. Accessed 25 Jun 2024."},{"key":"3949_CR3","unstructured":"World Health Organization. Global action plan on the public health response to dementia 2017 - 2025. 2017. https:\/\/www.who.int\/publications\/i\/item\/global-action-plan-on-the-public-health-response-to-dementia-2017---2025. Accessed 4 Dec 2023."},{"key":"3949_CR4","doi-asserted-by":"publisher","first-page":"e596","DOI":"10.1016\/S2214-109X(19)30074-9","volume":"7","author":"N Mukadam","year":"2019","unstructured":"Mukadam N, Sommerlad A, Huntley J, Livingston G. Population attributable fractions for risk factors for dementia in low-income and middle-income countries: an analysis using cross-sectional survey data. Lancet Glob Heal. 2019;7:e596-603.","journal-title":"Lancet Glob Heal"},{"key":"3949_CR5","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.jacc.2022.01.045","volume":"79","author":"C Li","year":"2022","unstructured":"Li C, Zhu Y, Ma Y, Hua R, Zhong B, Xie W. Association of Cumulative Blood Pressure With Cognitive Decline, Dementia, and Mortality. J Am Coll Cardiol. 2022;79:1321\u201335.","journal-title":"J Am Coll Cardiol"},{"key":"3949_CR6","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1001\/jama.2018.21442","volume":"321","author":"JD Williamson","year":"2019","unstructured":"Williamson JD, Pajewski NM, Auchus AP, Bryan RN, Chelune G, Cheung AK, et al. Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial. JAMA. 2019;321:553\u201361.","journal-title":"JAMA"},{"key":"3949_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac584","author":"R Peters","year":"2022","unstructured":"Peters R, Xu Y, Fitzgerald O, Aung HL, Beckett N, Bulpitt C, et al. Blood pressure lowering and prevention of dementia: an individual patient data meta-analysis. Eur Heart J. 2022. https:\/\/doi.org\/10.1093\/eurheartj\/ehac584.","journal-title":"Eur Heart J"},{"key":"3949_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1474-4422(19)30393-X","volume":"19","author":"J Ding","year":"2020","unstructured":"Ding J, Davis-Plourde KL, Sedaghat S, Tully PJ, Wang W, Phillips C, et al. Antihypertensive medications and risk for incident dementia and Alzheimer\u2019s disease: a meta-analysis of individual participant data from prospective cohort studies. Lancet Neurol. 2020;19:61\u201370.","journal-title":"Lancet Neurol"},{"key":"3949_CR9","doi-asserted-by":"publisher","first-page":"e267","DOI":"10.1212\/WNL.0000000000008732","volume":"94","author":"R Peters","year":"2020","unstructured":"Peters R, Yasar S, Anderson CS, Andrews S, Antikainen R, Arima H, et al. Investigation of antihypertensive class, dementia, and cognitive decline: A meta-analysis. Neurology. 2020;94:e267\u201381.","journal-title":"Neurology"},{"key":"3949_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrneurol.2015.250","volume":"12","author":"H Hampel","year":"2016","unstructured":"Hampel H, Lista S. Dementia: the rising global tide of cognitive impairment. Nat Rev Neurol. 2016;12:131\u20132.","journal-title":"Nat Rev Neurol"},{"key":"3949_CR11","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.jacc.2024.01.030","volume":"83","author":"F Rea","year":"2024","unstructured":"Rea F, Corrao G, Mancia G. Risk of Dementia During Antihypertensive Drug Therapy in the Elderly. J Am Coll Cardiol. 2024;83:1194\u2013203.","journal-title":"J Am Coll Cardiol"},{"key":"3949_CR12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13195-024-01467-y","volume":"16","author":"H Li","year":"2024","unstructured":"Li H, Wang M, Qian F, Wu Z, Liu W, Wang A, et al. Association between untreated and treated blood pressure levels and cognitive decline in community-dwelling middle-aged and older adults in China: a longitudinal study. Alzheimers Res Ther. 2024;16:104.","journal-title":"Alzheimers Res Ther"},{"key":"3949_CR13","doi-asserted-by":"publisher","first-page":"101365","DOI":"10.1016\/j.arr.2021.101365","volume":"69","author":"E Wagg","year":"2021","unstructured":"Wagg E, Blyth FM, Cumming RG, Khalatbari-Soltani S. Socioeconomic position and healthy ageing: A systematic review of cross-sectional and longitudinal studies. Ageing Res Rev. 2021;69:101365.","journal-title":"Ageing Res Rev"},{"key":"3949_CR14","doi-asserted-by":"publisher","first-page":"14911","DOI":"10.1073\/pnas.1915741117","volume":"117","author":"A Steptoe","year":"2020","unstructured":"Steptoe A, Zaninotto P. Lower socioeconomic status and the acceleration of aging: An outcome-wide analysis. Proc Natl Acad Sci. 2020;117:14911\u20137.","journal-title":"Proc Natl Acad Sci"},{"key":"3949_CR15","doi-asserted-by":"publisher","first-page":"e693","DOI":"10.1016\/S2666-7568(23)00211-8","volume":"4","author":"R Li","year":"2023","unstructured":"Li R, Li R, Xie J, Chen J, Liu S, Pan A, et al. Associations of socioeconomic status and healthy lifestyle with incident early-onset and late-onset dementia: a prospective cohort study. Lancet Heal Longev. 2023;4:e693-702.","journal-title":"Lancet Heal Longev"},{"key":"3949_CR16","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jval.2013.11.011","volume":"17","author":"MHDW Alsabbagh","year":"2014","unstructured":"Alsabbagh MHDW, Lemstra M, Eurich D, Lix LM, Wilson TW, Watson E, et al. Socioeconomic status and nonadherence to antihypertensive drugs: a systematic review and meta-analysis. Value Heal. 2014;17:288\u201396.","journal-title":"Value Heal"},{"key":"3949_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2014;43:61\u20138.","journal-title":"Int J Epidemiol"},{"key":"3949_CR18","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DEJ, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task F. Hypertension. 2018;71:1269\u2013324.","journal-title":"Hypertension"},{"key":"3949_CR19","doi-asserted-by":"publisher","first-page":"e2234208","DOI":"10.1001\/jamanetworkopen.2022.34208","volume":"5","author":"C Li","year":"2022","unstructured":"Li C, Ma Y, Yang C, Hua R, Xie W, Zhang L. Association of Cystatin C Kidney Function Measures With Long-term Deficit-Accumulation Frailty Trajectories and Physical Function Decline. JAMA Netw Open. 2022;5:e2234208.","journal-title":"JAMA Netw Open"},{"key":"3949_CR20","doi-asserted-by":"publisher","first-page":"n604","DOI":"10.1136\/bmj.n604","volume":"373","author":"Y-B Zhang","year":"2021","unstructured":"Zhang Y-B, Chen C, Pan X-F, Guo J, Li Y, Franco OH, et al. Associations of healthy lifestyle and socioeconomic status with mortality and incident cardiovascular disease: two prospective cohort studies. BMJ. 2021;373:n604.","journal-title":"BMJ"},{"key":"3949_CR21","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3233\/JAD-221162","volume":"93","author":"Y Ma","year":"2023","unstructured":"Ma Y, Li C, Hua R, Yang C, Xie W, Zhang L. Association Between Serum Cystatin C and Cognitive Decline Independently from Creatinine: Evidence from Two Nationally Representative Aging Cohorts. J Alzheimers Dis. 2023;93:459\u201369.","journal-title":"J Alzheimers Dis"},{"key":"3949_CR22","doi-asserted-by":"publisher","first-page":"afac071","DOI":"10.1093\/ageing\/afac071","volume":"51","author":"C Li","year":"2022","unstructured":"Li C, Ma Y, Hua R, Zheng F, Xie W. Long-term physical activity participation trajectories were associated with subsequent cognitive decline, risk of dementia and all-cause mortality among adults aged \u226550 years: a population-based cohort study. Age Ageing. 2022;51:afac071.","journal-title":"Age Ageing."},{"key":"3949_CR23","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1161\/STROKEAHA.120.033697","volume":"52","author":"C Li","year":"2021","unstructured":"Li C, Ma Y, Hua R, Yang Z, Zhong B, Wang H, et al. Dose-Response Relationship Between Long-Term Blood Pressure Variability and Cognitive Decline. Stroke. 2021;52:3249\u201357.","journal-title":"Stroke"},{"key":"3949_CR24","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1016\/j.jacc.2019.04.019","volume":"73","author":"W Xie","year":"2019","unstructured":"Xie W, Zheng F, Yan L, Zhong B. Cognitive decline before and after incident coronary events. J Am Coll Cardiol. 2019;73:3041\u201350.","journal-title":"J Am Coll Cardiol"},{"key":"3949_CR25","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1016\/j.scib.2021.02.018","volume":"66","author":"R Hua","year":"2021","unstructured":"Hua R, Ma Y, Li C, Zhong B, Xie W. Low levels of low-density lipoprotein cholesterol and cognitive decline. Sci Bull. 2021;66:1684\u201390.","journal-title":"Sci Bull"},{"key":"3949_CR26","doi-asserted-by":"publisher","first-page":"e072691","DOI":"10.1136\/bmj-2022-072691","volume":"380","author":"J Jia","year":"2023","unstructured":"Jia J, Zhao T, Liu Z, Liang Y, Li F, Li Y, et al. Association between healthy lifestyle and memory decline in older adults: 10 year, population based, prospective cohort study. BMJ. 2023;380:e072691.","journal-title":"BMJ"},{"key":"3949_CR27","doi-asserted-by":"publisher","first-page":"j2856","DOI":"10.1136\/bmj.j2856","volume":"358","author":"S Ahmadi-Abhari","year":"2017","unstructured":"Ahmadi-Abhari S, Guzman-Castillo M, Bandosz P, Shipley MJ, Muniz-Terrera G, Singh-Manoux A, et al. Temporal trend in dementia incidence since 2002 and projections for prevalence in England and Wales to 2040: modelling study. BMJ. 2017;358:j2856.","journal-title":"BMJ"},{"key":"3949_CR28","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/EDE.0b013e3182003276","volume":"22","author":"S Geneletti","year":"2011","unstructured":"Geneletti S, Mason A, Best N. Adjusting for selection effects in epidemiologic studies: why sensitivity analysis is the only \u201csolution.\u201d Epidemiology. 2011;22:36\u20139.","journal-title":"Epidemiology"},{"key":"3949_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/rssb.12027","volume":"76","author":"K Imai","year":"2014","unstructured":"Imai K, Ratkovic M. Covariate balancing propensity score. J R Stat Soc Ser B (Statistical Methodol). 2014;76:243\u201363.","journal-title":"J R Stat Soc Ser B (Statistical Methodol)."},{"key":"3949_CR30","doi-asserted-by":"publisher","first-page":"11688","DOI":"10.1038\/s41598-018-29974-7","volume":"8","author":"MH Cho","year":"2018","unstructured":"Cho MH, Shin DW, Chang S-A, Lee JE, Jeong S-M, Kim SH, et al. Association between cognitive impairment and poor antihypertensive medication adherence in elderly hypertensive patients without dementia. Sci Rep. 2018;8:11688.","journal-title":"Sci Rep"},{"key":"3949_CR31","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1111\/jocn.16106","volume":"31","author":"C-C Chou","year":"2022","unstructured":"Chou C-C, Chien L-Y, Liaw J-J, Wang C-J, Liu P-Y. Association between cognitive function and self-reported antihypertensive medication adherence among middle-aged and older hypertensive women. J Clin Nurs. 2022;31:2839\u201349.","journal-title":"J Clin Nurs"},{"key":"3949_CR32","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3389\/fpubh.2020.00231","volume":"8","author":"DJ McMaughan","year":"2020","unstructured":"McMaughan DJ, Oloruntoba O, Smith ML. Socioeconomic Status and Access to Healthcare: Interrelated Drivers for Healthy Aging. Front public Heal. 2020;8:231.","journal-title":"Front public Heal"},{"key":"3949_CR33","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12939-023-01887-6","volume":"22","author":"L Shi","year":"2023","unstructured":"Shi L, Tao L, Chen N, Liang H. Relationship between socioeconomic status and cognitive ability among Chinese older adults: the moderating role of social support. Int J Equity Health. 2023;22:70.","journal-title":"Int J Equity Health"},{"key":"3949_CR34","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1001\/jamapsychiatry.2018.1012","volume":"75","author":"D Cadar","year":"2018","unstructured":"Cadar D, Lassale C, Davies H, Llewellyn DJ, Batty GD, Steptoe A. Individual and Area-Based Socioeconomic Factors Associated With Dementia Incidence in England: Evidence From a 12-Year Follow-up in the English Longitudinal Study of Ageing. JAMA Psychiat. 2018;75:723\u201332.","journal-title":"JAMA Psychiat"},{"key":"3949_CR35","doi-asserted-by":"publisher","first-page":"e2110432","DOI":"10.1001\/jamanetworkopen.2021.10432","volume":"4","author":"JD Petersen","year":"2021","unstructured":"Petersen JD, Wehberg S, Packness A, Svensson NH, Hyldig N, Raunsgaard S, et al. Association of Socioeconomic Status With Dementia Diagnosis Among Older Adults in Denmark. JAMA Netw open. 2021;4:e2110432.","journal-title":"JAMA Netw open"},{"key":"3949_CR36","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1002\/alz.13770","volume":"20","author":"RT Muir","year":"2024","unstructured":"Muir RT, Hill MD, Black SE, Smith EE. Minimal clinically important difference in Alzheimer\u2019s disease: Rapid review. Alzheimers Dement. 2024;20:3352\u201363.","journal-title":"Alzheimers Dement"},{"key":"3949_CR37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jclinepi.2017.04.022","volume":"87","author":"AJ Streeter","year":"2017","unstructured":"Streeter AJ, Lin NX, Crathorne L, Haasova M, Hyde C, Melzer D, et al. Adjusting for unmeasured confounding in non-randomised longitudinal studies: a methodological review. J Clin Epidemiol. 2017;87:23\u201334.","journal-title":"J Clin Epidemiol"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-03949-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-03949-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-03949-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T11:11:35Z","timestamp":1740481895000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-025-03949-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3949"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-03949-8","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"assertion":[{"value":"17 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The CHARLS was approved by the Peking University Institutional Review Board (IRB00001052-11015), with all participants providing written informed consent before enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}